NEW YORK (GenomeWeb News) – Advanced Biological Laboratories said today it signed a non-exclusive agreement with Roche Diagnostics for the promotion of certain ABL products.

In particular, the deal is aimed at promoting ABL's next-generation sequencing platform called DeepChek with Roche's NGS systems, the 454 GS Junior and 454 GS FLX+, for molecular virology. The deal covers Europe, the Middle East, Africa, and Latin America.

DeepChek is a solution for managing and analyzing NGS data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.